Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (171-180 of 373) with videos related to

Pageof 38
Sort By:
BMC Women'S Health|August 29, 2025
Human papillomavirus infection among patients with cervical cancer in CambodiaJacob E Gardner, Kyle Jung, Michel Pluot, et al.
BMJ Open|October 5, 2021
Ovarian Cancer Epidemiology, Healthcare Access and Disparities (ORCHiD): methodology for a population-based study of black, Hispanic and white patients with ovarian cancerTomi Akinyemiju, April Deveaux, Lauren Wilson, et al.
Nature|November 8, 2005
Oncogenic pathway signatures in human cancers as a guide to targeted therapiesAndrea H Bild, Guang Yao, Jeffrey T Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2004
Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributionsSteven J Skates, Nora Horick, Yinhua Yu, et al.
Gynecologic Oncology Reports|June 16, 2025
A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancersStéphanie L Gaillard, Gloria Broadwater, Andrew Berchuck, et al.
Annals of Surgical Oncology|September 23, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJosé G Guillem, William C Wood, Jeffrey F Moley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJosé G Guillem, William C Wood, Jeffrey F Moley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancerHolly K Dressman, Andrew Berchuck, Gina Chan, et al.
Frontiers in Genetics|March 31, 2012
Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian CarcinomaLinda E Kelemen, Qinggang Wang, Irina Dinu, et al.
International Journal of Cancer|September 25, 2020
Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analysesJue-Sheng Ong, Eske M Derks, Mikael Eriksson, et al.
Pageof 38

Showing results (171-180 of 373) with videos related to

Sort By:
Pageof 38
BMC Women'S Health|August 29, 2025
Human papillomavirus infection among patients with cervical cancer in CambodiaJacob E Gardner, Kyle Jung, Michel Pluot, et al.
BMJ Open|October 5, 2021
Ovarian Cancer Epidemiology, Healthcare Access and Disparities (ORCHiD): methodology for a population-based study of black, Hispanic and white patients with ovarian cancerTomi Akinyemiju, April Deveaux, Lauren Wilson, et al.
Nature|November 8, 2005
Oncogenic pathway signatures in human cancers as a guide to targeted therapiesAndrea H Bild, Guang Yao, Jeffrey T Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2004
Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributionsSteven J Skates, Nora Horick, Yinhua Yu, et al.
Gynecologic Oncology Reports|June 16, 2025
A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancersStéphanie L Gaillard, Gloria Broadwater, Andrew Berchuck, et al.
Annals of Surgical Oncology|September 23, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJosé G Guillem, William C Wood, Jeffrey F Moley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJosé G Guillem, William C Wood, Jeffrey F Moley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancerHolly K Dressman, Andrew Berchuck, Gina Chan, et al.
Frontiers in Genetics|March 31, 2012
Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian CarcinomaLinda E Kelemen, Qinggang Wang, Irina Dinu, et al.
International Journal of Cancer|September 25, 2020
Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analysesJue-Sheng Ong, Eske M Derks, Mikael Eriksson, et al.
Pageof 38